CFLAR and gastric cancer: c-FLIP was found overexpressed in many human tumor types, such as prostate carcinoma (96.3%), hepatocellular carcinoma (83.7%), colorectal (68.8%) and gastric cancer (57.1%) and over 90% of Hodgkin lymphomas [84,85,86,87,88].